| Nov 5 |
Royalty Pharma Q3 2024 Earnings Preview
|
| Nov 4 |
Syndax, Royalty Pharma enter into $350M royalty funding deal
|
| Nov 4 |
Royalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for Niktimvo
|
| Nov 4 |
Syndax Pharmaceuticals and Royalty Pharma Enter into $350 Million Royalty Funding Agreement for Niktimvo™
|
| Nov 3 |
Morgan Stanley Predicts Up to 670% Jump for These 2 ‘Strong Buy’ Stocks
|
| Oct 16 |
Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024
|
| Oct 11 |
Royalty Pharma Declares Fourth Quarter 2024 Dividend
|
| Oct 9 |
Royalty Pharma PLC (RPRX) Q2 2024 Earnings Call Highlights: Surpassing Growth Expectations and ...
|
| Oct 9 |
Royalty Pharma plc (RPRX): Among The Stocks With Biggest Upside Potential According to Hedge Funds
|
| Oct 8 |
Peering Into Royalty Pharma's Recent Short Interest
|
